EP1572079A3 - Mammalian cdr mimetibodies, compositions, methods and uses - Google Patents

Mammalian cdr mimetibodies, compositions, methods and uses

Info

Publication number
EP1572079A3
EP1572079A3 EP03718053.6A EP03718053A EP1572079A3 EP 1572079 A3 EP1572079 A3 EP 1572079A3 EP 03718053 A EP03718053 A EP 03718053A EP 1572079 A3 EP1572079 A3 EP 1572079A3
Authority
EP
European Patent Office
Prior art keywords
mimetibodies
compositions
uses
methods
cdr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03718053.6A
Other languages
German (de)
French (fr)
Other versions
EP1572079A4 (en
EP1572079A2 (en
Inventor
George A. Heavner
David M. Knight
Bernard J. Scallon
John Ghrayeb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US36879102P priority Critical
Priority to US368791P priority
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Priority to PCT/US2003/009139 priority patent/WO2003084477A2/en
Publication of EP1572079A3 publication Critical patent/EP1572079A3/en
Publication of EP1572079A2 publication Critical patent/EP1572079A2/en
Publication of EP1572079A4 publication Critical patent/EP1572079A4/en
Application status is Withdrawn legal-status Critical

Links

EP03718053A 2002-03-29 2003-03-24 Mammalian cdr mimetibodies, compositions, methods and uses Withdrawn EP1572079A4 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US36879102P true 2002-03-29 2002-03-29
US368791P 2002-03-29
PCT/US2003/009139 WO2003084477A2 (en) 2002-03-29 2003-03-24 Mammalian cdr mimetibodies, compositions, methods and uses

Publications (3)

Publication Number Publication Date
EP1572079A3 true EP1572079A3 (en) 2005-09-09
EP1572079A2 EP1572079A2 (en) 2005-09-14
EP1572079A4 EP1572079A4 (en) 2006-09-06

Family

ID=28791903

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03718053A Withdrawn EP1572079A4 (en) 2002-03-29 2003-03-24 Mammalian cdr mimetibodies, compositions, methods and uses

Country Status (3)

Country Link
EP (1) EP1572079A4 (en)
AU (1) AU2003222069A1 (en)
WO (1) WO2003084477A2 (en)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2490409A1 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses
US7897384B2 (en) * 2003-09-08 2011-03-01 Ethicon, Inc. Chondrocyte therapeutic delivery system
US7927599B2 (en) 2003-09-08 2011-04-19 Ethicon, Inc. Chondrocyte therapeutic delivery system
SI1675579T1 (en) * 2003-09-30 2009-12-31 Centocor Ortho Biotech Inc Human epo mimetic hinge core mimetibodies, compositions, methods and uses
DE10353175A1 (en) 2003-11-14 2005-06-16 Müller-Hermelink, Hans Konrad, Prof. Dr. Human monoclonal antibody with fatliquoring effect
EP1531162A1 (en) 2003-11-14 2005-05-18 Hans Konrad Müller-Hermelink Adenocarcinoma specific antibody SAM-6, and uses thereof
EP1696952A4 (en) * 2003-12-23 2007-11-07 Centocor Inc Anti-retroviral agents, compositions, methods and uses
ITMI20041569A1 (en) * 2004-07-30 2004-10-30 Tecnogen Scpa "Specific peptide ligands for immunoglobulins"
US20060084145A1 (en) 2004-09-27 2006-04-20 Anderson Glenn M sRAGE mimetibody, compositions, methods and uses
CA2701032A1 (en) 2007-09-27 2009-04-02 Amgen Inc. Pharmaceutical formulations
EP2219602A1 (en) 2007-11-15 2010-08-25 Amgen, Inc Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
US9175078B2 (en) 2008-01-25 2015-11-03 Amgen Inc. Ferroportin antibodies and methods of use
EP2294087B1 (en) 2008-05-01 2014-05-14 Amgen, Inc. Anti-hepcidin antibodies and methods of use
WO2010056981A2 (en) 2008-11-13 2010-05-20 Massachusetts General Hospital Methods and compositions for regulating iron homeostasis by modulation bmp-6
IT1395137B1 (en) * 2009-08-05 2012-09-05 Spider Biotech S R L New peptides antipatogeni
MX344382B (en) 2009-10-23 2016-12-14 Amgen Inc * Vial adapter and system.
BR112012031121A2 (en) 2010-06-07 2016-11-01 Amgen Inc drug delivery device
MX341790B (en) 2011-03-31 2016-09-02 Amgen Inc Vial adapter and system.
EP3335747A1 (en) 2011-10-14 2018-06-20 Amgen Inc. Injector and method of assembly
EP2917227B1 (en) 2012-11-08 2019-01-16 Phi Pharma SA C4s proteoglycan specific transporter molecules
EP2922590A1 (en) 2012-11-21 2015-09-30 Amgen Inc. Drug delivery device
CN105263514B (en) 2013-03-15 2019-04-26 本质生命科学有限公司 Anti- hepcidin antibody and application thereof
US20150374919A1 (en) 2013-03-22 2015-12-31 Amgen Inc. Injector and method of assembly
EP3060275B1 (en) 2013-10-24 2019-07-03 Amgen Inc. Injector and method of assembly
JP2016538096A (en) 2013-10-24 2016-12-08 アムジエン・インコーポレーテツド Drug delivery system with temperature sensing control
WO2015119906A1 (en) 2014-02-05 2015-08-13 Amgen Inc. Drug delivery system with electromagnetic field generator
CN106413779A (en) 2014-05-07 2017-02-15 安姆根有限公司 Autoinjector with shock reducing elements
WO2015187797A1 (en) 2014-06-03 2015-12-10 Amgen Inc. Controllable drug delivery system and method of use
EP3197915A4 (en) 2014-09-22 2018-12-19 Intrinsic Lifesciences LLC Humanized anti-hepcidin antibodies and uses thereof
JP2017530817A (en) 2014-10-14 2017-10-19 アムジエン・インコーポレーテツド Drug injection device with visual and audible indicators
JP2017538512A (en) 2014-12-19 2017-12-28 アムジエン・インコーポレーテツド Drug delivery device including live button or user interface field
JP2017538511A (en) 2014-12-19 2017-12-28 アムジエン・インコーポレーテツド Drug delivery device with proximity sensor
US20180036476A1 (en) 2015-02-17 2018-02-08 Amgen Inc. Drug delivery device with vacuum assisted securement and/or feedback
WO2017039786A1 (en) 2015-09-02 2017-03-09 Amgen Inc. Syringe assembly adapter for a syringe
US20180318526A1 (en) 2015-12-09 2018-11-08 Amgen Inc. Auto-injector with signaling cap
WO2017120178A1 (en) 2016-01-06 2017-07-13 Amgen Inc. Auto-injector with signaling electronics
BR112018014250A2 (en) * 2016-01-13 2018-12-18 Regeneron Pharma rodent, isolated rodent cell or tissue, immortalized cell, rodent embryonic stem cell, rodent embryo, and methods for producing a rodent and an antibody
EP3429663A1 (en) 2016-03-15 2019-01-23 Amgen Inc. Reducing probability of glass breakage in drug delivery devices
US20190192766A1 (en) 2016-04-29 2019-06-27 Amgen Inc. Drug Delivery Device with Messaging Label
WO2017192287A1 (en) 2016-05-02 2017-11-09 Amgen Inc. Syringe adapter and guide for filling an on-body injector
CA3018426A1 (en) 2016-05-13 2017-11-16 Amgen Inc. Vial sleeve assembly
EP3458988A1 (en) 2016-05-16 2019-03-27 Amgen Inc. Data encryption in medical devices with limited computational capability
EP3465124A1 (en) 2016-06-03 2019-04-10 Amgen Inc. Impact testing apparatuses and methods for drug delivery devices
EP3478342A1 (en) 2016-07-01 2019-05-08 Amgen Inc. Drug delivery device having minimized risk of component fracture upon impact events
US20190328965A1 (en) 2016-08-17 2019-10-31 Amgen Inc. Drug delivery device with placement detection
EP3532127A1 (en) 2016-10-25 2019-09-04 Amgen Inc. On-body injector
WO2018136398A1 (en) 2017-01-17 2018-07-26 Amgen Inc. Injection devices and related methods of use and assembly
AU2018220538A1 (en) 2017-02-17 2019-06-27 Amgen Inc. Drug delivery device with sterile fluid flowpath and related method of assembly
WO2018152073A1 (en) 2017-02-17 2018-08-23 Amgen Inc. Insertion mechanism for drug delivery device
AU2018231107A1 (en) 2017-03-06 2019-08-01 Amgen Inc. Drug delivery device with activation prevention feature
AU2018230546A1 (en) 2017-03-07 2019-08-22 Amgen Inc. Needle insertion by overpressure
SG11201908062QA (en) 2017-03-09 2019-09-27 Amgen Inc Insertion mechanism for drug delivery device
WO2018172219A1 (en) 2017-03-20 2018-09-27 F. Hoffmann-La Roche Ag Method for in vitro glycoengineering of an erythropoiesis stimulating protein
SG11201907676PA (en) 2017-03-28 2019-09-27 Amgen Inc Plunger rod and syringe assembly system and method
WO2018226565A1 (en) 2017-06-08 2018-12-13 Amgen Inc. Torque driven drug delivery device
WO2018226515A1 (en) 2017-06-08 2018-12-13 Amgen Inc. Syringe assembly for a drug delivery device and method of assembly
WO2018236619A1 (en) 2017-06-22 2018-12-27 Amgen Inc. Device activation impact/shock reduction
WO2018237225A1 (en) 2017-06-23 2018-12-27 Amgen Inc. Electronic drug delivery device comprising a cap activated by a switch assembly
WO2019014014A1 (en) 2017-07-14 2019-01-17 Amgen Inc. Needle insertion-retraction system having dual torsion spring system
WO2019018169A1 (en) 2017-07-21 2019-01-24 Amgen Inc. Gas permeable sealing member for drug container and methods of assembly
WO2019022950A1 (en) 2017-07-25 2019-01-31 Amgen Inc. Drug delivery device with container access system and related method of assembly
WO2019022951A1 (en) 2017-07-25 2019-01-31 Amgen Inc. Drug delivery device with gear module and related method of assembly
WO2019032482A2 (en) 2017-08-09 2019-02-14 Amgen Inc. Hydraulic-pneumatic pressurized chamber drug delivery system
WO2019036181A1 (en) 2017-08-18 2019-02-21 Amgen Inc. Wearable injector with sterile adhesive patch
US20190060562A1 (en) 2017-08-22 2019-02-28 Amgen Inc. Needle insertion mechanism for drug delivery device
WO2019070472A1 (en) 2017-10-04 2019-04-11 Amgen Inc. Flow adapter for drug delivery device
WO2019070552A1 (en) 2017-10-06 2019-04-11 Amgen Inc. Drug delivery device with interlock assembly and related method of assembly
WO2019074579A1 (en) 2017-10-09 2019-04-18 Amgen Inc. Drug delivery device with drive assembly and related method of assembly
WO2019090079A1 (en) 2017-11-03 2019-05-09 Amgen Inc. System and approaches for sterilizing a drug delivery device
WO2019089178A1 (en) 2017-11-06 2019-05-09 Amgen Inc. Drug delivery device with placement and flow sensing
WO2019090303A1 (en) 2017-11-06 2019-05-09 Amgen Inc. Fill-finish assemblies and related methods
WO2019094138A1 (en) 2017-11-10 2019-05-16 Amgen Inc. Plungers for drug delivery devices
WO2019099324A1 (en) 2017-11-16 2019-05-23 Amgen Inc. Door latch mechanism for drug delivery device
WO2019099322A1 (en) 2017-11-16 2019-05-23 Amgen Inc. Autoinjector with stall and end point detection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6235294A (en) * 1993-02-02 1994-08-29 Scripps Research Institute, The Methods for producing polypeptide binding sites
CA2490409A1 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses

Similar Documents

Publication Publication Date Title
AP2280A (en) Compositions and methods for increasing telomeraseactivity.
EP1376427A3 (en) SPAM detector with challenges
AU2003282548A1 (en) Nano-chem-fet based biosensors
AU2003265340A1 (en) Microelectronic adaptors, assemblies and methods
AU2003277103A1 (en) Creamer compositions and methods of making and using the same
AU2003273000A1 (en) Stable solid preparations
AU2003215172A1 (en) Message accessing
AU2003239909A1 (en) Enhanced-service provision
AU2003214879A1 (en) Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
EP1549269A4 (en) Cyclodextrin-based materials, compositions and uses related thereto
AU2003249738A1 (en) Ostoscope
AU2003297193A1 (en) Meta-web
AU2003273433A1 (en) Cartridge-operated coffee-machine
AU2003219116A1 (en) Fragrance compositions
AU2003217234A1 (en) Modulator- amplifier
AU2001279227A1 (en) Anti-TNF antibodies, compositions, methods and uses
AU2003239690A1 (en) Jettable compositions
AU2003216036A1 (en) Telephone network messaging
AU2003233465A1 (en) Structural member
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
EP1615878A4 (en) Compounds, compositions and methods
AU2002348988A1 (en) Composition comprising Wenguanguo extracts, methods for preparing same and uses thereof
AU2002359884A1 (en) An improved control - hold mode
EP1623011A4 (en) IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
PL375599A1 (en) Multi-purpose polymers, methods and compositions

Legal Events

Date Code Title Description
AX Extension of the european patent to

Countries concerned: ALLTLVMK

17P Request for examination filed

Effective date: 20041028

AK Designated contracting states:

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Extension of the european patent to

Countries concerned: ALLTLVMK

AK Designated contracting states:

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

RIC1 Classification (correction)

Ipc: 7A 61K 39/395 B

Ipc: 7C 07H 21/04 A

Ipc: 7C 12N 15/00 B

A4 Supplementary search report

Effective date: 20060803

17Q First examination report

Effective date: 20080328

18D Deemed to be withdrawn

Effective date: 20080808